NICE decision on AF drug challenged by heart charity

NICE's decision not to approve dronedarone, a novel anti-arrhythmic drug, for use in the NHS in England has been challenged by the Atrial Fibrillation Association.

Electrocardiogram (ECG) of electrical activity in the heart in a case of auricular fibrillation (Photograph: SPL)
Electrocardiogram (ECG) of electrical activity in the heart in a case of auricular fibrillation (Photograph: SPL)

The drug has been approved by the European Medicines Agency, but provisional guidelines published by NICE last month recommended that dronedarone should not be made available on the NHS. 

The Atrial Fibrillation Association (AFA) has now called on people to appeal against this decision by 28 January, the deadline for responding to NICE's draft guidelines.

‘We are urging MPs, patients with AF and professionals involved in heart-rhythm care to speak out and reply to this appraisal document by NICE,' said Trudie Lobban, founder and chief executive of AFA.

‘If dronedarone is not approved, it will have a detrimental effect on the lives of thousands of people who could be helped to live a safer, healthier and active life.'

Dronedarone has been shown in large scale trials to significantly decrease the incidence of AF in patients suffering from the condition. Unlike older anti-arrhythmic drugs it has far fewer side effects, which makes it popular with patients.

The Atrial Fibrillation Association estimates that 40,000 patients could benefit from the drug. The charity said that hundreds of healthcare professionals and MPs have written to NICE to voice their concerns.

NICE will review its decision in February in consultation with patients and healthcare professionals.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Former Brexit secretary backs vitamin D supplements to beat COVID-19

Former Brexit secretary backs vitamin D supplements to beat COVID-19

The NHS should provide 10 times the current daily recommended amount of vitamin D...

Identifying patients experiencing domestic violence and abuse in general practice

Identifying patients experiencing domestic violence and abuse in general practice

Dr Vasumathy Sivarajasingam describes a pilot project in her practice that used a...

Long COVID could ‘wreak havoc’ on NHS workforce and disrupt vaccine rollout

Long COVID could ‘wreak havoc’ on NHS workforce and disrupt vaccine rollout

High rates of COVID-19 infection and the impact of long COVID could 'wreak havoc'...

GPs can give COVID and flu jabs at same time, says NHS England

GPs can give COVID and flu jabs at same time, says NHS England

GPs can now administer COVID-19 and flu jabs at the same time, according to updated...

Areas hit hardest by COVID-19 fall behind on vaccine campaign

Areas hit hardest by COVID-19 fall behind on vaccine campaign

Regions of England hit hardest by COVID-19 cases have fallen behind the rest of the...

COVID-19 pandemic drives first recorded dip in patients registered with GPs

COVID-19 pandemic drives first recorded dip in patients registered with GPs

A rise in deaths and reduced immigration during the COVID-19 pandemic saw the first-ever...